IP Verse

Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc. - IPR2024-00260

Explore the PTAB proceeding IPR2024-00260 filed by Celltrion, Inc. et al. against Regeneron Pharmaceuticals, Inc. on Dec 14, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2024-00260
Filing Date
Dec 14, 2023
Petitioner
Celltrion, Inc. et al.
Respondent
Regeneron Pharmaceuticals, Inc.
Status
Terminated-Adverse Judgment
Respondent Application Number
17352892
Respondent Tech Center
1600
Respondent Patent Number
11253572
Institution Decision Date
Jan 30, 2024
Termination Date
Jul 23, 2024

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2024-00260.

TypeName
Petitioner CounselGreen, Loraet al
Respondent CounselBrausa, Adamet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.